Community Healthcare Trust (CHCT) 10-Q 7 May 19 2019 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2019	Apr. 30, 2019
Document and Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2019
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q1
Entity Registrant Name	Community Healthcare Trust Inc
Entity Central Index Key	0001631569
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Entity Emerging Growth Company	true
Entity Ex Transition Period	true
Entity Small Business	true
Entity Common Stock, Shares Outstanding		18,862,792

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2019	Dec. 31, 2018
Real estate properties
Land and land improvements	$ 52,520	$ 50,270
Buildings, improvements, and lease intangibles	425,763	394,527
Personal property	135	133
Total real estate properties	478,418	444,930
Less accumulated depreciation	(60,544)	(55,298)
Total real estate properties, net	417,874	389,632
Cash and cash equivalents	3,868	2,007
Restricted cash	166	385
Other assets, net	34,822	34,546
Total assets	456,730	426,570
Liabilities
Debt, net	179,117	147,766
Accounts payable and accrued liabilities	3,351	3,196
Other liabilities	4,579	3,949
Total liabilities	187,047	154,911
Commitments and contingencies
Stockholders' Equity
Preferred stock, $0.01 par value; 50,000,000 shares authorized; none issued and outstanding	0	0
Common stock, $0.01 par value; 450,000,000 shares authorized; 18,862,792 and 18,634,502 shares issued and outstanding at March 31, 2019 and December 31, 2018, respectively	189	186
Additional paid-in capital	342,654	337,180
Cumulative net income	10,628	9,178
Accumulated other comprehensive (loss) income	(642)	633
Cumulative dividends	(83,146)	(75,518)
Total stockholders’ equity	269,683	271,659
Total liabilities and stockholders' equity	$ 456,730	$ 426,570

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2019	Dec. 31, 2018
Statement of Financial Position [Abstract]
Preferred Stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred Stock, shares authorized	50,000,000	50,000,000
Preferred Stock, shares issued	0	0
Preferred Stock, shares outstanding	0	0
Common Stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common Stock, shares authorized	450,000,000	450,000,000
Common Stock, shares issued	18,862,792	18,634,502
Common Stock, shares outstanding	18,862,792	18,634,502

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
REVENUES
Rental income	$ 12,898	$ 11,075
Revenues	13,441	11,429
EXPENSES
Property operating	3,075	2,364
General and administrative	1,785	1,193
Depreciation and amortization	5,246	4,916
Expenses	10,106	8,473
INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAXES AND OTHER ITEMS	3,335	2,956
Interest expense	(2,054)	(1,268)
Interest and other income, net	169	184
INCOME FROM CONTINUING OPERATIONS	1,450	1,872
NET INCOME	$ 1,450	$ 1,872
NET INCOME PER COMMON SHARE:
Net income per common share – Basic (in dollars per share)	$ 0.06	$ 0.09
Net income per common share – Diluted (in dollars per share)	$ 0.06	$ 0.09
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING-BASIC (in shares)	17,954,670	17,573,683
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING-DILUTED (in shares)	17,954,670	17,573,683
Other operating interest
REVENUES
Revenue	$ 543	$ 354

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Statement of Comprehensive Income [Abstract]
NET INCOME	$ 1,450	$ 1,872
Other comprehensive income (loss):
(Decrease) increase in fair value of cash flow hedges	(1,213)	906
Reclassification for amounts recognized as interest expense	62	(68)
Total other comprehensive (loss) income	(1,275)	974
COMPREHENSIVE INCOME	$ 175	$ 2,846

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock [Member]	Additional Paid in Capital [Member]	Cumulative Net Income [Member]	Accumulated Other Comprehensive Income [Member]	Cumulative Dividends [Member]
Beginning Balance at Dec. 31, 2017	$ 283,374	$ 181	$ 324,303	$ 4,775	$ 258	$ (46,143)
Beginning Balance, shares at Dec. 31, 2017		18,085,798
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation, shares		94,001
Stock-based compensation	616	$ 1	615
Unrecognized gain (loss) on cash flow hedges	906				906
Reclassification adjustment for (gains) losses included in net income (interest expense)	68				68
Net income	1,872			1,872
Dividends to common stockholders	(7,226)					(7,226)
Ending Balance, shares at Mar. 31, 2018		18,179,799
Ending Balance at Mar. 31, 2018	279,610	$ 182	324,918	6,647	1,232	(53,369)
Beginning Balance at Dec. 31, 2017	$ 283,374	$ 181	324,303	4,775	258	(46,143)
Beginning Balance, shares at Dec. 31, 2017		18,085,798
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net of issuance costs (in shares)	334,700
Ending Balance, shares at Dec. 31, 2018		18,634,502
Ending Balance at Dec. 31, 2018	$ 271,659	$ 186	337,180	9,178	633	(75,518)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net of issuance costs (in shares)	143,600	143,600
Issuance of common stock, net of issuance costs	$ 4,624	$ 2	4,622
Stock-based compensation, shares		84,690
Stock-based compensation	853	$ 1	852
Unrecognized gain (loss) on cash flow hedges	(1,213)				(1,213)
Reclassification adjustment for (gains) losses included in net income (interest expense)	(62)				(62)
Net income	1,450			1,450
Dividends to common stockholders	(7,628)					(7,628)
Ending Balance, shares at Mar. 31, 2019		18,862,792
Ending Balance at Mar. 31, 2019	$ 269,683	$ 189	$ 342,654	$ 10,628	$ (642)	$ (83,146)

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Stockholders' Equity (Parenthetical) - $ / shares	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Cumulative Dividends [Member]
Dividends to common stockholders, per share (in dollars per share)	$ 0.4075	$ 0.3975

Condensed Consolidated Statem_5

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
OPERATING ACTIVITIES
Net income	$ 1,450	$ 1,872
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	5,421	5,133
Stock-based compensation	853	616
Straight-line rent receivable	(336)	(415)
Deferred income tax expense (benefit)	17	(132)
Changes in operating assets and liabilities:
Other assets	(194)	(696)
Accounts payable and accrued liabilities	155	(309)
Other liabilities	(36)	(121)
Net cash provided by operating activities	7,330	5,948
INVESTING ACTIVITIES
Acquisitions of real estate	(32,743)	(12,721)
Acquisitions of notes receivable	0	(2,201)
Proceeds from the repayment of notes receivable	31	17
Capital expenditures on existing real estate properties	(622)	(1,444)
Net cash used in investing activities	(33,334)	(16,349)
FINANCING ACTIVITIES
Net repayments on revolving credit facility	(43,000)	(22,000)
Term loan borrowings	75,000	40,000
Mortgage note repayments	(27)	0
Dividends paid	(7,628)	(7,226)
Net proceeds from issuance of common stock	4,724	0
Equity issuance costs	(100)	0
Debt issuance costs	(1,323)	(218)
Net cash provided by financing activities	27,646	10,556
Increase in cash and cash equivalents and restricted cash	1,642	155
Cash and cash equivalents and restricted cash, beginning of period	2,392	2,130
Cash and cash equivalents and restricted cash, end of period	4,034	2,285
Supplemental Cash Flow Information:
Interest paid	1,783	1,105
Invoices accrued for construction, tenant improvement and other capitalized costs	81	712
Reclassification between accounts and notes receivable	40	0
Reclassification of registration statement costs incurred in prior year to equity issuance costs	100	0
(Decrease) increase in fair value of cash flow hedges	$ (1,213)	$ 906

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2019
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Business Overview Community Healthcare Trust Incorporated (the ‘‘Company’’, ‘‘we’’, ‘‘our’’) was organized in the State of Maryland on March 28, 2014. The Company is a fully-integrated healthcare real estate company that owns and acquires real estate properties that are leased to hospitals, doctors, healthcare systems or other healthcare service providers in our target submarkets. As of March 31, 2019 , the Company had investments of approximately $478.4 million in 105 real estate properties, located in 29 states, totaling approximately 2.3 million square feet in the aggregate. Basis of Presentation The Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. They do not include all of the information and footnotes required by GAAP for complete financial statements. This interim financial information should be read in conjunction with the financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018 . Management believes that all adjustments of a normal, recurring nature considered necessary for a fair presentation have been included. This interim financial information does not necessarily represent or indicate what the operating results will be for the year ending December 31, 2019 . All material intercompany accounts and transactions have been eliminated. Use of Estimates in the Condensed Consolidated Financial Statements Preparation of the Condensed Consolidated Financial Statements in accordance with GAAP requires management to make estimates and assumptions that affect amounts reported in the Condensed Consolidated Financial Statements and accompanying notes. Actual results may materially differ from those estimates. Reclassifications Tenant reimbursements totaling $1.4 million on the Company's Condensed Consolidated Statements of Income for the three months ended March 31, 2018 were reclassified into rental income. Income Taxes The Company has elected to be taxed as a real estate investment trust ("REIT"), as defined under the Internal Revenue Code of 1986, as amended (the "Code"). The Company and one subsidiary have also elected for that subsidiary to be treated as a taxable REIT subsidiary ("TRS"), which is subject to federal and state income taxes. No provision has been made for federal income taxes for the REIT; however, the Company has recorded income tax expense or benefit for the TRS to the extent applicable. The Company intends at all times to qualify as a REIT under the Code. The Company must distribute at least 90% per annum of its REIT taxable income to its stockholders (which is computed without regard to the dividends paid deduction or net capital gain and which does not necessarily equal net income as calculated in accordance with GAAP) and meet other requirements to continue to qualify as a REIT. New Accounting Pronouncements Recently Adopted Accounting Pronouncements Lease Accounting In February 2016, the Financial Accounting Standards Board (the "FASB") issued Accounting Standards Update ("ASU") 2016-02, Leases; in January 2018, the FASB issued ASU 2018-01, Leases - Land Easement Practical Expedient for Transition to Topic 842; in July 2018, the FASB issued ASU 2018-10, Codification Improvements to Topic 842, Leases and ASU 2018-11, Leases - Targeted Improvements; and in December 2018, the FASB issued ASU 2018-20, Narrow-Scope Improvements for Lessors. The Company adopted this group of ASUs, collectively referred to as Topic 842, on January 1, 2019. Topic 842 superseded the existing standards for lease accounting (Topic 840, Leases). The Company elected to utilize the following practical expedients provided by Topic 842: • the package of practical expedients that allows an entity not to reassess upon adoption (i) whether an expired or existing contract contains a lease, (ii) whether a lease classification related to expired or existing lease arrangements, and (iii) whether costs incurred on expired or existing leases qualify as initial direct costs, and • as a lessor, the practical expedient not to separate certain non-lease components, such as common area maintenance, from the lease component if (i) the timing and pattern of transfer are the same for the nonlease component and associated lease component, and (ii) the lease component would be classified as an operating lease if accounted for separately. Topic 842 requires lessees to record most leases on their balance sheet through a right-of-use ("ROU") model, in which a lessee records a ROU asset and a lease liability on their balance sheet. Leases with terms that are 12 months or less or leases that are clearly insignificant do not need to be accounted for under the ROU model. Lessees will account for leases as financing or operating leases, with the classification affecting the timing and pattern of expense recognition in the income statement. Lease expense will be recognized based on the effective interest method for leases accounted for as finance leases and on a straight-line basis over the term of the lease for leases accounted for as operating leases. The accounting by a lessor under Topic 842 is largely unchanged from that of Topic 840. Under Topic 842, lessors will continue to account for leases as a sales-type, direct-financing, or operating. A lease will be treated as a sale if it is considered to transfer control of the underlying asset to the lessee. A lease will be classified as direct-financing if risks and rewards are conveyed without the transfer of control. Otherwise, the lease is treated as an operating lease. Topic 842 requires accounting for a transaction as a financing in a sale leaseback when the seller-lessee is provided an option to purchase the property from the landlord at the tenant's option. The Company expects that this provision could change the accounting for these types of leases in the future. Topic 842 also includes the concept of separating lease and nonlease components. Under Topic 842, nonlease components, such as common area maintenance, would be accounted for under Topic 606 and separated from the lease payments. However, the Company elected the lessor practical expedient allowing the Company to not separate these components when certain conditions are met. With this election, the Company combined tenant reimbursements with rental income on its Condensed Consolidated Income Statements. Additionally, we will recognize a charge to rental income for amounts deemed uncollectible. Further, the Company has historically only capitalized direct leasing costs, such as leasing commissions. While the new standard revises the treatment of indirect leasing costs and permits the capitalization and amortization only of direct leasing costs, the Company does not expect an impact to its financial statements related to the capitalization of leasing costs. Also, the Narrow-Scope Improvements for Lessors under ASU 2018-20 allows the Company to continue to exclude from revenue costs paid by our tenants on our behalf directly to third parties, such as property taxes and insurance. Topic 842 provided two transition alternatives. The Company adopted the standard based on the prospective optional transition method, in which leases for comparative periods continue to be accounted for in accordance with Topic 840. Upon adoption, where the Company is the lessee, we recorded a right of use asset and a related operating lease liability, each totaling approximately $0.1 million , related to one ground lease which will have minimal impact on the recognition of future ground lease expense. The right of use lease asset is included in other assets and the operating lease liability is included in other liabilities on the Company's Condensed Consolidated Balance Sheet. Derivatives and Hedge Accounting In October 2018, the FASB issued an update, ASU 2018-16, Inclusion of the Secured Overnight Financing Rate (SOFR) Overnight Index Swap (OIS) Rate as a Benchmark Interest Rate for Hedge Accounting Purposes to ASC Topic 815, Derivatives and Hedging. ASU 2018-16 expands the list of U.S. benchmark interest rates permitted in the application of hedge accounting by adding the OIS rate based on SOFR as an eligible benchmark interest rate. ASU 2018-16 is effective for interim and annual reporting periods in fiscal years beginning after December 15, 2018. We adopted this update effective January 1, 2019. The adoption of this update did not have an impact on our Condensed Consolidated Financial Statements. Recently Issued Accounting Pronouncements Financial Instruments-Credit Losses In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments-Credit Losses, which changes the impairment model for most financial assets and certain other instruments. For trade and other receivables, held-to-maturity debt securities, loans and other instruments, companies will be required to use a new current expected credit loss ("CECL") model that generally will result in the earlier recognition of allowances for losses. For available-for-sale debt securities with unrealized losses, companies will measure credit losses in a manner similar to what they do today, except that the losses will be recognized as allowances rather than as reductions in the amortized cost of the securities. Companies will have to disclose significantly more information, including information they use to track credit quality by year of origination for most financing receivables. Companies will apply the standard’s provisions as a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is adopted. This standard is effective for the Company on January 1, 2020 with early adoption permitted. In August 2018, the FASB issued a proposal that would amend the ASU to clarify that receivables arising from leases would not be within the scope of the ASU but rather would be accounted for under the leasing standard. The Company continues to monitor the FASB's activity relating to this ASU.

Real Estate Investments

Real Estate Investments	3 Months Ended
	Mar. 31, 2019
Real Estate [Abstract]
Real Estate Investments	Real Estate Investments At March 31, 2019 , the Company had investments of approximately $478.4 million in 105 real estate properties. The following table summarizes the Company's real estate investments. (Dollars in thousands) Number of Facilities Land and Land Improvements Buildings, Improvements, and Lease Intangibles Personal Property Total Accumulated Depreciation Medical office buildings: Florida 5 $ 4,608 $ 29,285 $ — $ 33,893 $ 4,515 Ohio 6 3,638 26,483 — 30,121 5,508 Texas 3 3,115 15,591 — 18,706 4,456 Illinois 2 1,136 11,831 — 12,967 2,664 Kansas 3 2,455 14,933 — 17,388 4,189 Iowa 1 2,241 9,014 — 11,255 2,468 Other states 15 4,355 35,828 — 40,183 4,649 35 21,548 142,965 — 164,513 28,449 Physician clinics: Kansas 2 610 6,921 — 7,531 1,485 Illinois 6 2,888 9,539 — 12,427 540 Florida 4 253 9,484 — 9,737 912 Other states 9 2,903 21,462 — 24,365 3,459 21 6,654 47,406 — 54,060 6,396 Surgical centers and hospitals: Louisiana 1 1,683 21,353 — 23,036 1,244 Michigan 2 637 8,278 — 8,915 2,434 Illinois 2 2,349 8,222 — 10,571 1,411 Florida 1 271 7,069 — 7,340 810 Arizona 2 576 5,389 — 5,965 1,603 Other states 7 2,130 17,857 — 19,987 4,074 15 7,646 68,168 — 75,814 11,576 Specialty centers: Illinois 3 3,489 24,733 — 28,222 2,117 Other states 22 5,170 38,344 — 43,514 7,331 25 8,659 63,077 — 71,736 9,448 Behavioral facilities: West Virginia 1 2,138 22,897 — 25,035 880 Illinois 1 1,300 18,803 — 20,103 1,332 Indiana 2 1,126 6,040 — 7,166 351 Other states 3 1,411 12,840 — 14,251 499 7 5,975 60,580 — 66,555 3,062 Inpatient rehabilitation facilities: Texas 1 1,515 27,001 — 28,516 82 1 1,515 27,001 — 28,516 82 Long-term acute care hospitals: Indiana 1 523 14,405 — 14,928 1,222 1 523 14,405 — 14,928 1,222 Corporate property — — 2,161 135 2,296 309 Total real estate investments 105 $ 52,520 $ 425,763 $ 135 $ 478,418 $ 60,544

Real Estate Leases

Real Estate Leases	3 Months Ended
	Mar. 31, 2019
Leases [Abstract]
Real Estate Leases	Real Estate Leases The Company’s properties are generally leased pursuant to non-cancelable, fixed-term operating leases with expiration dates through 2034 . The Company’s leases generally require the lessee to pay minimum rent, with fixed rent renewal terms or increases based on a Consumer Price Index and and may also include additional rent, which may include taxes (including property taxes), insurance, maintenance and other operating costs associated with the leased property. Some leases provide the lessee, during the term of the lease, with an option or right of first refusal to purchase the leased property. Some leases also allow the lessee to renew or extend their lease term or in some cases terminate their lease, based on conditions provided in the lease. Future minimum lease payments under the non-cancelable operating leases due the Company for the years ending December 31, as of March 31, 2019 , are as follows (in thousands): 2019 (nine months ending December 31) $ 32,823 2020 41,304 2021 38,200 2022 34,688 2023 30,177 2024 and thereafter 156,754 $ 333,946 Straight-line rental income Rental income is recognized as earned over the life of the lease agreement on a straight-line basis. Straight-line rent included in rental income was approximately $0.3 million and $0.4 million , respectively, for the three months ended March 31, 2019 and 2018 . Deferred revenue Rent received but not yet earned is deferred until such time it is earned. Deferred revenue, included in other liabilities, was approximately $ 1.5 million and $1.6 million , respectively, at March 31, 2019 and December 31, 2018 .

Real Estate Acquisitions

Real Estate Acquisitions	3 Months Ended
	Mar. 31, 2019
Business Combinations [Abstract]
Real Estate Acquisitions	Real Estate Acquisitions During the first quarter of 2019, the Company acquired two real estate properties totaling approximately 83,000 square feet for an aggregate purchase price and cash consideration of approximately $32.7 million . Upon acquisition, the properties were 100% leased in the aggregate with lease expirations in 2029 . Amounts reflected in revenues and net income for the three months ended March 31, 2019 for these properties were approximately $0.4 million and $0.2 million , respectively. Transaction costs totaling approximately $0.1 million related to these asset acquisitions were capitalized in the period and included in real estate assets.

Mortgage and Other Notes Receiv

Mortgage and Other Notes Receivable	3 Months Ended
	Mar. 31, 2019
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
Mortgage and Other Notes Receivable	Mortgage and Other Notes Receivable The Company had one mortgage note receivable outstanding as of December 31, 2017 with a principal balance of $10.6 million and interest receivable of $0.6 million , which is included in other assets. The borrower and several related entities (the "Borrower") filed for voluntary bankruptcy on June 23, 2017. At the time of filing for bankruptcy, the Borrower was current on all obligations to the Company, but no payments were received during the bankruptcy. On December 28, 2017, the Company purchased $11.45 million face value of certain promissory notes, secured by accounts receivable of the Borrower, for $8.75 million from a syndicate of banks, a $2.7 million discount to face value, and in the first quarter of 2018 acquired $2.2 million of certain promissory notes, secured by the operations of two facilities related to the Borrower, but were not included in the bankruptcy, for a total investment in these promissory notes of approximately $10.95 million . On April 25, 2018, the Company provided a $23.0 million loan, included in other assets, to a newly formed company (Newco), secured by all assets and ownership interests in seven long-term acute care hospitals and one inpatient rehabilitation hospital that, along with a series of investments by the management of Newco, allowed Newco to acquire certain assets of the Borrower. Also on April 25, 2018, $10.95 million of the promissory notes discussed above, approximately $0.26 million of interest on those promissory notes, approximately $0.25 million in fees and reimbursement of expenses, and approximately $6.7 million principal and accrued interest related to its mortgage note receivable were satisfied with proceeds from the loan. In addition, the Company received title to the property previously financed by the mortgage note receivable at an approximate $4.5 million valuation. No impairment was recognized by the Company.

Debt, net

Debt, net	3 Months Ended
	Mar. 31, 2019
Debt Disclosure [Abstract]
Debt, net	Debt, net The table below details the Company's debt as of March 31, 2019 and December 31, 2018 . Balance as of (Dollars in thousands) March 31, 2019 December 31, 2018 Maturity Dates Revolving Credit Facility $ — $ 43,000 3/23 A-1 Term Loan, net 49,778 49,759 3/22 A-2 Term Loan, net 49,735 49,722 3/24 A-3 Term Loan, net 74,341 — 3/26 Mortgage Note Payable 5,263 5,285 5/24 $ 179,117 $ 147,766 The Company's second amended and restated credit facility (the "Credit Facility") is by and among Community Healthcare OP, LP, the Company, the lenders from time to time party thereto, and SunTrust Bank, as Administrative Agent. The Company’s material subsidiaries are guarantors of the obligations under the Credit Facility. The Company entered into a third amendment to its Credit Facility (the "Third Amendment") on March 29, 2019 , which added a $75.0 million term loan (the "A-3 Term Loan"), which matures on March 29, 2026 , extended the maturity of the revolving credit facility (the "Revolving Credit Facility") to March 29, 2023 , improved pricing on the Credit Facility, and adjusted certain financial covenants. The Company paid approximately $1.3 million in fees and expenses related to the Third Amendment, of which $0.7 million was related to the Revolving Credit Facility and was recorded as deferred financing costs, included in Other Assets, and $0.6 million was related to the A-3 Term Loan and was recorded as deferred financing costs, included in Debt, net, on the Company's Condensed Consolidated Balance Sheet. The Credit Facility, as amended, provides for a $150.0 million Revolving Credit Facility and $175.0 million in term loans (the "Term Loans"). The Credit Facility, through the accordion feature, allows borrowings up to a total of $525.0 million including the ability to add and fund additional term loans. The Revolving Credit Facility matures on March 29, 2023 and includes one 12 -month option to extend the maturity date of the Revolving Credit Facility, subject to the satisfaction of certain conditions. The Term Loans include a five -year term loan facility in the aggregate principal amount of $50.0 million (the "A-1 Term Loan"), which matures on March 29, 2022 , a seven -year term loan facility in the aggregate principal amount of $50.0 million (the "A-2 Term Loan"), which matures on March 29, 2024 and the new seven -year, $75.0 million A-3 Term Loan, which matures on March 29, 2026 . Amounts outstanding under the Revolving Credit Facility, as amended, bear annual interest at a floating rate that is based, at the Company’s option, on either: (i) LIBOR plus 1.25% to 1.90% or (ii) a base rate plus 0.25% to 0.90% in each case, depending upon the Company’s leverage ratio. In addition, the Company is obligated to pay an annual fee equal to 0.25% of the amount of the unused portion of the Revolving Credit Facility if amounts borrowed are greater than 33.3% of the borrowing capacity under the Revolving Credit Facility and 0.35% of the unused portion of the Revolving Credit Facility if amounts borrowed are less than or equal to 33.3% of the borrowing capacity under the Revolving Credit Facility. The Company repaid the amounts outstanding under its Revolving Credit Facility with proceeds from the A-3 Term Loan and therefore had the full borrowing capacity under the Revolving Credit Facility of $150.0 million at March 31, 2019. Amounts outstanding under the Term Loans, as amended, bear annual interest at a floating rate that is based, at the Company’s option, on either: (i) LIBOR plus 1.25% to 2.30% or (ii) a base rate plus 0.25% to 1.30% , in each case, depending upon the Company’s leverage ratio. In addition, the Company is obligated to pay an annual fee equal to 0.35% of the amount of the unused portion of the Term Loans. The Company has entered into interest rate swaps to fix the interest rates on the Term Loans. See Note 7 for more details on the interest rate swaps. At March 31, 2019 , the Company had drawn the full $175.0 million under the Term Loans which had a fixed weighted average interest rate under the swaps of approximately 4.569% . The Company’s ability to borrow under the Credit Facility is subject to its ongoing compliance with a number of customary affirmative and negative covenants, including limitations with respect to liens, indebtedness, distributions, mergers, consolidations, investments, restricted payments and asset sales, as well as financial maintenance covenants. The Company was in compliance with its financial covenants under its Credit Facility as of March 31, 2019 .

Derivative Financial Instrument

Derivative Financial Instruments	3 Months Ended
	Mar. 31, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	Derivative Financial Instruments Risk Management Objective of Using Derivatives The Company may use derivative financial instruments, including interest rate swaps, caps, options, floors and other interest rate derivative contracts, to hedge all or a portion of the interest rate risk associated with its borrowings. The principal objective of such arrangements is to minimize the risks and/or costs associated with the Company’s operating and financial structure as well as to hedge specific anticipated transactions. The Company does not intend to utilize derivatives for speculative or other purposes other than interest rate risk management. The use of derivative financial instruments carries certain risks, including the risk that the counterparties to these contractual arrangements are not able to perform under the agreements. To mitigate this risk, the Company only enters into derivative financial instruments with counterparties with high credit ratings and with major financial institutions with which the Company and its affiliates may also have other financial relationships. The Company does not anticipate that any of the counterparties will fail to meet their obligations. Cash Flow Hedges of Interest Rate Risk The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps and/or caps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable-rate amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. Interest rate caps designated as cash flow hedges involve the receipt of variable-rate amounts if interest rates rise above the cap strike rate on the contract. As of March 31, 2019 , the Company had seven outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk for notional amounts totaling $175.0 million . The table below presents the fair value of the Company’s derivative financial instruments as well as their classification on the Condensed Consolidated Balance Sheets as of March 31, 2019 and December 31, 2018 . Asset Derivatives Fair Value at Liability Derivatives Fair Value at March 31, 2019 December 31, 2018 Balance Sheet Classification March 31, 2019 December 31, 2018 Balance Sheet Classification Interest rate swaps $ 215 $ 902 Other assets $ 857 $ 98 Other Liabilities The changes in the fair value of derivatives designated and that qualify as cash flow hedges are recorded in accumulated other comprehensive income and are subsequently reclassified to interest expense in the period that the hedged forecasted transaction affects earnings. Amounts reported in accumulated other comprehensive income related to derivatives will be reclassified to interest expense as interest payments are made on the Company’s Term Loans. During the next twelve months, the Company estimates that an additional $0.2 million will be reclassified from other comprehensive income ("OCI") as a decrease to interest expense. The table below details the location in the financial statements of the gain or loss recognized on interest rate derivatives designated as cash flow hedges for the three months ended March 31, 2019 and 2018 . Three Months Ended March 31, (Dollars in thousands) 2019 2018 Amount of unrealized (loss) gain recognized in OCI on derivative $ (1,213 ) $ 906 Amount of (gain) loss reclassified from accumulated OCI into interest expense $ (62 ) $ 68 Total Interest Expense presented in the Condensed Consolidated Statements of Income in which the effects of the cash flow hedges are recorded $ 2,054 $ 1,268 Credit-risk-related Contingent Feature s As of March 31, 2019, the fair value of derivatives in a net liability position including accrued interest but excluding any adjustment for nonperformance risk related to these agreements was $0.7 million . As of March 31, 2019, the Company has not posted any collateral related to these agreements and was not in breach of any agreement provisions. If the Company had breached any of these provisions, it could have been required to settle its obligations under the agreements at their aggregate termination value of approximately $0.7 million at March 31, 2019.

Stockholders' Equity

Stockholders' Equity	3 Months Ended
	Mar. 31, 2019
Equity [Abstract]
Stockholders' Equity	Stockholders’ Equity Common Stock The following table provides a reconciliation of the beginning and ending common stock balances for the three months ended March 31, 2019 and for the year ended December 31, 2018 : Three Months Ended Year Ended December 31, 2018 Balance, beginning of period 18,634,502 18,085,798 Issuance of common stock 143,600 334,700 Restricted stock-based awards 84,690 214,004 Balance, end of period 18,862,792 18,634,502 ATM Program On August 7, 2018, the Company entered into an at-the-market offering program ("ATM Program") with Sandler O’Neill & Partners, L.P., Evercore Group L.L.C., SunTrust Robinson Humphrey, Inc., BB&T Capital Markets, a division of BB&T Securities, LLC, Fifth Third Securities, Inc. and Janney Montgomery Scott LLC, as sales agents (collectively, the “Agents”), under which the Company may issue and sell shares of its common stock, par value $0.01 per share (the “Common Stock”), having an aggregate gross sales price of up to $100.0 million (the “Shares”) from time to time through or to one or more of the Agents, as may be determined by the Company in its sole discretion, subject to the terms and conditions of the Agreement and applicable law. During the first quarter of 2019 , the Company issued, through its ATM Program, 143,600 shares of common stock at an average gross sales price of $33.57 per share and received net proceeds of approximately $4.7 million . As of March 31, 2019 , the Company had approximately $84.8 million remaining that may be issued under the ATM Program.

Net Income Per Common Share

Net Income Per Common Share	3 Months Ended
	Mar. 31, 2019
Earnings Per Share [Abstract]
Net Income Per Common Share	Net Income Per Common Share The following table sets forth the computation of basic and diluted net income per common share. Three Months Ended (Dollars in thousands, except per share data) 2019 2018 Net income $ 1,450 $ 1,872 Participating securities' share in earnings (324 ) (241 ) Net income, less participating securities' share in earnings $ 1,126 $ 1,631 Weighted average Common Shares outstanding Weighted average Common Shares outstanding 18,735,673 18,164,132 Unvested restricted shares (781,003 ) (590,449 ) Weighted average Common Shares outstanding–Basic 17,954,670 17,573,683 Dilutive potential common shares — — Weighted average Common Shares outstanding –Diluted 17,954,670 17,573,683 Basic Net Income per Common Share $ 0.06 $ 0.09 Diluted Net Income per Common Share $ 0.06 $ 0.09

Incentive Plan

Incentive Plan	3 Months Ended
	Mar. 31, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Incentive Plan	Incentive Plan Under the Company's 2014 Incentive Plan, as amended, awards may be made in the form of restricted stock, cash or a combination of both. Compensation expense recognized from the amortization of the value of the Company's officer, employee and director shares over the applicable vesting periods during the three months ended March 31, 2019 and 2018 was approximately $0.9 million and $0.6 million , respectively. A summary of the activity under the 2014 Incentive Plan for the three months ended March 31, 2019 and 2018 is included in the table below. Three Months Ended March 31, 2019 2018 Stock-based awards, beginning of period 709,487 512,115 Stock in lieu of compensation 42,525 47,027 Stock awards 42,165 46,974 Total stock granted 84,690 94,001 Vested shares — — Stock-based awards, end of period 794,177 606,116

Other Assets

Other Assets	3 Months Ended
	Mar. 31, 2019
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Other Assets	Other Assets Items included in Other assets, net on the Company's Condensed Consolidated Balance Sheets as of March 31, 2019 and December 31, 2018 are detailed in the table below. Balance as of (Dollars in thousands) March 31, 2019 December 31, 2018 Notes receivable $ 24,119 $ 24,110 Accounts and interest receivables 2,092 2,158 Straight-line rent receivables 3,593 3,254 Prepaid assets 515 487 Deferred financing costs, net 848 318 Leasing commissions, net 862 790 Deferred tax asset 2,008 2,024 Fair value of interest rate swaps 215 902 Above-market intangible assets, net 162 168 Right of use leased asset 141 — Other 267 335 $ 34,822 $ 34,546 The Company's $24.1 million in notes receivable at March 31, 2019 include mainly the following notes. Interest related to these notes is included in Other Operating Interest on the Company's Condensed Consolidated Statements of Income. • On April 25, 2018, the Company provided a $23.0 million loan to a newly formed company (Newco), secured by all assets and ownership interests in seven long-term acute care hospitals and one inpatient rehabilitation hospital. The loan, which matures on May 1, 2031, currently bears interest at 9% per annum, with principal payments beginning in May 2021. See Note 5 for more detail. • On December 31, 2018, the Company entered into notes with a tenant totaling $0.9 million . The notes bear interest at 9% per annum and mature on December 31, 2019. The Company identified the borrowers of these notes as variable interest entities ("VIEs"), but management determined that the Company was not the primary beneficiary of the VIEs because we lack either directly or through related parties any material impact in the activities that impact the borrowers' economic performance. We are not obligated to provide support beyond our stated commitment to the borrowers, and accordingly our maximum exposure to loss as a result of this relationship is limited to the amount of our outstanding notes receivable. The VIEs that we have identified at March 31, 2019 are summarized in the table below. Classification Carrying Amount (in millions) Maximum Exposure to Loss (in millions) Notes receivable $ 0.9 $ 0.9 Note receivable $ 23.0 $ 23.0 Highlands Transition Update As previously announced, the Company experienced payment issues with the old operator of Highlands Hospital ("Highlands"). Effective February 11, 2019, the Company signed a transition agreement (the "Transition Agreement"), to transition the property to a new operator and signed a lease with a new operator. The old operator and new operator have signed an asset purchase agreement pursuant to which the new operator will take over the facility. In addition, the old operator and new operator have signed a management agreement and the new operator is currently managing Highlands pursuant to the management agreement. The new operator continues to perform due diligence and is in the process of preparing for transfer of licenses and related items customary for these types of transactions. We cannot provide assurance as to the timing, or whether, this transaction will actually close. The new lease will be effective upon the transfer of the licenses to the new operator, which is anticipated to happen in the second half of 2019. The new lease provides for rental payments approximately equal to the amounts due under the previous agreements with the old operator. The Company is receiving monthly payments under the Transition Agreement which approximate the amounts due from the old operator under the previous agreements. These payments are to continue as long as the Transition Agreement is in place. The Transition Agreement will terminate when the licenses are transferred to the new operator, at which time the new lease will become effective. Since the Transition Agreement became effective in February, the Company only received payments during the first quarter for February and March and thus did not recognize revenue for the month of January representing approximately $0.3 million . In addition, the Company incurred professional fees (legal and accounting) totaling over $0.1 million related to the workout and transition. The Transition Agreement includes provisions for the Company to receive payment for the amounts due from the old operator that remain unpaid. The Company anticipates collecting all amounts due.

Fair Value of Financial Instrum

Fair Value of Financial Instruments	3 Months Ended
	Mar. 31, 2019
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	Fair Value of Financial Instruments The following methods and assumptions were used to estimate the fair value of each class of financial instruments for which it is practical to estimate the fair value. Cash and cash equivalents and restricted cash - The carrying amount approximates the fair value. Notes receivable - The fair value is estimated using cash flow analyses, based on an assumed market rate of interest or at a rate consistent with the rates on notes carried by the Company and are classified as level 2 in the hierarchy. Borrowings under our Credit Facility - The carrying amount approximates the fair value because the borrowings are based on variable market interest rates. Derivative financial instruments - The fair value is estimated using discounted cash flow techniques. These techniques incorporate primarily level 2 inputs. The market inputs are utilized in the discounted cash flow calculation considering the instrument’s term, notional amount, discount rate and credit risk. Significant inputs to the derivative valuation model for interest rate swaps are observable in active markets and are classified as level 2 in the hierarchy. Mortgage note payable - The fair value is estimated using cash flow analyses which are based on an assumed market rate of interest or at a rate consistent with the rates on mortgage notes assumed by the Company and are classified as level 2 in the hierarchy. The table below details the fair values and carrying values for our notes receivable, interest rate swaps, and mortgage note payable at March 31, 2019 and December 31, 2018 , using level 2 inputs. March 31, 2019 December 31, 2018 (Dollars in thousands) Carrying Value Fair Value Carrying Value Fair Value Notes receivable $ 24,119 $ 23,948 $ 24,110 $ 23,936 Interest rate swap asset $ 215 $ 215 $ 902 $ 902 Interest rate swap liability $ 857 $ 857 $ 269 $ 269 Mortgage note payable $ 5,365 $ 5,277 $ 5,391 $ 5,307

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2019
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events Dividend Declared On May 1, 2019 , the Company’s Board of Directors declared a quarterly common stock dividend in the amount of $0.41 per share. The dividend is payable on May 31, 2019 to stockholders of record on May 17, 2019 . Subsequent Acquistion On April 30, 2019, the Company acquired one real estate property that was newly constructed totaling approximately 81,000 square feet for an aggregate purchase price and cash consideration of approximately $27.0 million . Upon acquisition, the property was 100.0% leased with lease expiration in 2034 . The Company funded the acquisition with proceeds from the Company's Revolving Credit Facility totaling $23.0 million with the remainder from cash on hand.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2019
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. They do not include all of the information and footnotes required by GAAP for complete financial statements. This interim financial information should be read in conjunction with the financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018 . Management believes that all adjustments of a normal, recurring nature considered necessary for a fair presentation have been included. This interim financial information does not necessarily represent or indicate what the operating results will be for the year ending December 31, 2019 . All material intercompany accounts and transactions have been eliminated.
Use of Estimates in the Condensed Consolidated Financial Statements	Use of Estimates in the Condensed Consolidated Financial Statements Preparation of the Condensed Consolidated Financial Statements in accordance with GAAP requires management to make estimates and assumptions that affect amounts reported in the Condensed Consolidated Financial Statements and accompanying notes. Actual results may materially differ from those estimates.
Reclassifications	Reclassifications Tenant reimbursements totaling $1.4 million on the Company's Condensed Consolidated Statements of Income for the three months ended March 31, 2018 were reclassified into rental income.
Income Taxes	Income Taxes The Company has elected to be taxed as a real estate investment trust ("REIT"), as defined under the Internal Revenue Code of 1986, as amended (the "Code"). The Company and one subsidiary have also elected for that subsidiary to be treated as a taxable REIT subsidiary ("TRS"), which is subject to federal and state income taxes. No provision has been made for federal income taxes for the REIT; however, the Company has recorded income tax expense or benefit for the TRS to the extent applicable. The Company intends at all times to qualify as a REIT under the Code. The Company must distribute at least 90% per annum of its REIT taxable income to its stockholders (which is computed without regard to the dividends paid deduction or net capital gain and which does not necessarily equal net income as calculated in accordance with GAAP) and meet other requirements to continue to qualify as a REIT.
New Accounting Pronouncements	New Accounting Pronouncements Recently Adopted Accounting Pronouncements Lease Accounting In February 2016, the Financial Accounting Standards Board (the "FASB") issued Accounting Standards Update ("ASU") 2016-02, Leases; in January 2018, the FASB issued ASU 2018-01, Leases - Land Easement Practical Expedient for Transition to Topic 842; in July 2018, the FASB issued ASU 2018-10, Codification Improvements to Topic 842, Leases and ASU 2018-11, Leases - Targeted Improvements; and in December 2018, the FASB issued ASU 2018-20, Narrow-Scope Improvements for Lessors. The Company adopted this group of ASUs, collectively referred to as Topic 842, on January 1, 2019. Topic 842 superseded the existing standards for lease accounting (Topic 840, Leases). The Company elected to utilize the following practical expedients provided by Topic 842: • the package of practical expedients that allows an entity not to reassess upon adoption (i) whether an expired or existing contract contains a lease, (ii) whether a lease classification related to expired or existing lease arrangements, and (iii) whether costs incurred on expired or existing leases qualify as initial direct costs, and • as a lessor, the practical expedient not to separate certain non-lease components, such as common area maintenance, from the lease component if (i) the timing and pattern of transfer are the same for the nonlease component and associated lease component, and (ii) the lease component would be classified as an operating lease if accounted for separately. Topic 842 requires lessees to record most leases on their balance sheet through a right-of-use ("ROU") model, in which a lessee records a ROU asset and a lease liability on their balance sheet. Leases with terms that are 12 months or less or leases that are clearly insignificant do not need to be accounted for under the ROU model. Lessees will account for leases as financing or operating leases, with the classification affecting the timing and pattern of expense recognition in the income statement. Lease expense will be recognized based on the effective interest method for leases accounted for as finance leases and on a straight-line basis over the term of the lease for leases accounted for as operating leases. The accounting by a lessor under Topic 842 is largely unchanged from that of Topic 840. Under Topic 842, lessors will continue to account for leases as a sales-type, direct-financing, or operating. A lease will be treated as a sale if it is considered to transfer control of the underlying asset to the lessee. A lease will be classified as direct-financing if risks and rewards are conveyed without the transfer of control. Otherwise, the lease is treated as an operating lease. Topic 842 requires accounting for a transaction as a financing in a sale leaseback when the seller-lessee is provided an option to purchase the property from the landlord at the tenant's option. The Company expects that this provision could change the accounting for these types of leases in the future. Topic 842 also includes the concept of separating lease and nonlease components. Under Topic 842, nonlease components, such as common area maintenance, would be accounted for under Topic 606 and separated from the lease payments. However, the Company elected the lessor practical expedient allowing the Company to not separate these components when certain conditions are met. With this election, the Company combined tenant reimbursements with rental income on its Condensed Consolidated Income Statements. Additionally, we will recognize a charge to rental income for amounts deemed uncollectible. Further, the Company has historically only capitalized direct leasing costs, such as leasing commissions. While the new standard revises the treatment of indirect leasing costs and permits the capitalization and amortization only of direct leasing costs, the Company does not expect an impact to its financial statements related to the capitalization of leasing costs. Also, the Narrow-Scope Improvements for Lessors under ASU 2018-20 allows the Company to continue to exclude from revenue costs paid by our tenants on our behalf directly to third parties, such as property taxes and insurance. Topic 842 provided two transition alternatives. The Company adopted the standard based on the prospective optional transition method, in which leases for comparative periods continue to be accounted for in accordance with Topic 840. Upon adoption, where the Company is the lessee, we recorded a right of use asset and a related operating lease liability, each totaling approximately $0.1 million , related to one ground lease which will have minimal impact on the recognition of future ground lease expense. The right of use lease asset is included in other assets and the operating lease liability is included in other liabilities on the Company's Condensed Consolidated Balance Sheet. Derivatives and Hedge Accounting In October 2018, the FASB issued an update, ASU 2018-16, Inclusion of the Secured Overnight Financing Rate (SOFR) Overnight Index Swap (OIS) Rate as a Benchmark Interest Rate for Hedge Accounting Purposes to ASC Topic 815, Derivatives and Hedging. ASU 2018-16 expands the list of U.S. benchmark interest rates permitted in the application of hedge accounting by adding the OIS rate based on SOFR as an eligible benchmark interest rate. ASU 2018-16 is effective for interim and annual reporting periods in fiscal years beginning after December 15, 2018. We adopted this update effective January 1, 2019. The adoption of this update did not have an impact on our Condensed Consolidated Financial Statements. Recently Issued Accounting Pronouncements Financial Instruments-Credit Losses In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments-Credit Losses, which changes the impairment model for most financial assets and certain other instruments. For trade and other receivables, held-to-maturity debt securities, loans and other instruments, companies will be required to use a new current expected credit loss ("CECL") model that generally will result in the earlier recognition of allowances for losses. For available-for-sale debt securities with unrealized losses, companies will measure credit losses in a manner similar to what they do today, except that the losses will be recognized as allowances rather than as reductions in the amortized cost of the securities. Companies will have to disclose significantly more information, including information they use to track credit quality by year of origination for most financing receivables. Companies will apply the standard’s provisions as a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is adopted. This standard is effective for the Company on January 1, 2020 with early adoption permitted. In August 2018, the FASB issued a proposal that would amend the ASU to clarify that receivables arising from leases would not be within the scope of the ASU but rather would be accounted for under the leasing standard. The Company continues to monitor the FASB's activity relating to this ASU.

Real Estate Investments (Tables

Real Estate Investments (Tables)	3 Months Ended
	Mar. 31, 2019
Real Estate [Abstract]
Schedule of real estate property investments	At March 31, 2019 , the Company had investments of approximately $478.4 million in 105 real estate properties. The following table summarizes the Company's real estate investments. (Dollars in thousands) Number of Facilities Land and Land Improvements Buildings, Improvements, and Lease Intangibles Personal Property Total Accumulated Depreciation Medical office buildings: Florida 5 $ 4,608 $ 29,285 $ — $ 33,893 $ 4,515 Ohio 6 3,638 26,483 — 30,121 5,508 Texas 3 3,115 15,591 — 18,706 4,456 Illinois 2 1,136 11,831 — 12,967 2,664 Kansas 3 2,455 14,933 — 17,388 4,189 Iowa 1 2,241 9,014 — 11,255 2,468 Other states 15 4,355 35,828 — 40,183 4,649 35 21,548 142,965 — 164,513 28,449 Physician clinics: Kansas 2 610 6,921 — 7,531 1,485 Illinois 6 2,888 9,539 — 12,427 540 Florida 4 253 9,484 — 9,737 912 Other states 9 2,903 21,462 — 24,365 3,459 21 6,654 47,406 — 54,060 6,396 Surgical centers and hospitals: Louisiana 1 1,683 21,353 — 23,036 1,244 Michigan 2 637 8,278 — 8,915 2,434 Illinois 2 2,349 8,222 — 10,571 1,411 Florida 1 271 7,069 — 7,340 810 Arizona 2 576 5,389 — 5,965 1,603 Other states 7 2,130 17,857 — 19,987 4,074 15 7,646 68,168 — 75,814 11,576 Specialty centers: Illinois 3 3,489 24,733 — 28,222 2,117 Other states 22 5,170 38,344 — 43,514 7,331 25 8,659 63,077 — 71,736 9,448 Behavioral facilities: West Virginia 1 2,138 22,897 — 25,035 880 Illinois 1 1,300 18,803 — 20,103 1,332 Indiana 2 1,126 6,040 — 7,166 351 Other states 3 1,411 12,840 — 14,251 499 7 5,975 60,580 — 66,555 3,062 Inpatient rehabilitation facilities: Texas 1 1,515 27,001 — 28,516 82 1 1,515 27,001 — 28,516 82 Long-term acute care hospitals: Indiana 1 523 14,405 — 14,928 1,222 1 523 14,405 — 14,928 1,222 Corporate property — — 2,161 135 2,296 309 Total real estate investments 105 $ 52,520 $ 425,763 $ 135 $ 478,418 $ 60,544

Real Estate Leases (Tables)

Real Estate Leases (Tables)	3 Months Ended
	Mar. 31, 2019
Leases [Abstract]
Schedule of future minimum lease payments for operating leases	Future minimum lease payments under the non-cancelable operating leases due the Company for the years ending December 31, as of March 31, 2019 , are as follows (in thousands): 2019 (nine months ending December 31) $ 32,823 2020 41,304 2021 38,200 2022 34,688 2023 30,177 2024 and thereafter 156,754 $ 333,946

Debt, net (Tables)

Debt, net (Tables)	3 Months Ended
	Mar. 31, 2019
Debt Disclosure [Abstract]
Schedule of debt	The table below details the Company's debt as of March 31, 2019 and December 31, 2018 . Balance as of (Dollars in thousands) March 31, 2019 December 31, 2018 Maturity Dates Revolving Credit Facility $ — $ 43,000 3/23 A-1 Term Loan, net 49,778 49,759 3/22 A-2 Term Loan, net 49,735 49,722 3/24 A-3 Term Loan, net 74,341 — 3/26 Mortgage Note Payable 5,263 5,285 5/24 $ 179,117 $ 147,766

Derivative Financial Instrume_2

Derivative Financial Instruments (Tables)	3 Months Ended
	Mar. 31, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of fair value of derivative instruments on balance sheet	The table below presents the fair value of the Company’s derivative financial instruments as well as their classification on the Condensed Consolidated Balance Sheets as of March 31, 2019 and December 31, 2018 . Asset Derivatives Fair Value at Liability Derivatives Fair Value at March 31, 2019 December 31, 2018 Balance Sheet Classification March 31, 2019 December 31, 2018 Balance Sheet Classification Interest rate swaps $ 215 $ 902 Other assets $ 857 $ 98 Other Liabilities
Schedule of derivative gain (loss)	The table below details the location in the financial statements of the gain or loss recognized on interest rate derivatives designated as cash flow hedges for the three months ended March 31, 2019 and 2018 . Three Months Ended March 31, (Dollars in thousands) 2019 2018 Amount of unrealized (loss) gain recognized in OCI on derivative $ (1,213 ) $ 906 Amount of (gain) loss reclassified from accumulated OCI into interest expense $ (62 ) $ 68 Total Interest Expense presented in the Condensed Consolidated Statements of Income in which the effects of the cash flow hedges are recorded $ 2,054 $ 1,268

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	3 Months Ended
	Mar. 31, 2019
Equity [Abstract]
Schedule of reconciliation of common stock	The following table provides a reconciliation of the beginning and ending common stock balances for the three months ended March 31, 2019 and for the year ended December 31, 2018 : Three Months Ended Year Ended December 31, 2018 Balance, beginning of period 18,634,502 18,085,798 Issuance of common stock 143,600 334,700 Restricted stock-based awards 84,690 214,004 Balance, end of period 18,862,792 18,634,502

Net Income Per Common Share (Ta

Net Income Per Common Share (Tables)	3 Months Ended
	Mar. 31, 2019
Earnings Per Share [Abstract]
Schedule of earnings per share	The following table sets forth the computation of basic and diluted net income per common share. Three Months Ended (Dollars in thousands, except per share data) 2019 2018 Net income $ 1,450 $ 1,872 Participating securities' share in earnings (324 ) (241 ) Net income, less participating securities' share in earnings $ 1,126 $ 1,631 Weighted average Common Shares outstanding Weighted average Common Shares outstanding 18,735,673 18,164,132 Unvested restricted shares (781,003 ) (590,449 ) Weighted average Common Shares outstanding–Basic 17,954,670 17,573,683 Dilutive potential common shares — — Weighted average Common Shares outstanding –Diluted 17,954,670 17,573,683 Basic Net Income per Common Share $ 0.06 $ 0.09 Diluted Net Income per Common Share $ 0.06 $ 0.09

Incentive Plan (Tables)

Incentive Plan (Tables)	3 Months Ended
	Mar. 31, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Summary of nonvested restricted stock activity	A summary of the activity under the 2014 Incentive Plan for the three months ended March 31, 2019 and 2018 is included in the table below. Three Months Ended March 31, 2019 2018 Stock-based awards, beginning of period 709,487 512,115 Stock in lieu of compensation 42,525 47,027 Stock awards 42,165 46,974 Total stock granted 84,690 94,001 Vested shares — — Stock-based awards, end of period 794,177 606,116

Other Assets (Tables)

Other Assets (Tables)	3 Months Ended
	Mar. 31, 2019
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Schedule of Other Assets	Items included in Other assets, net on the Company's Condensed Consolidated Balance Sheets as of March 31, 2019 and December 31, 2018 are detailed in the table below. Balance as of (Dollars in thousands) March 31, 2019 December 31, 2018 Notes receivable $ 24,119 $ 24,110 Accounts and interest receivables 2,092 2,158 Straight-line rent receivables 3,593 3,254 Prepaid assets 515 487 Deferred financing costs, net 848 318 Leasing commissions, net 862 790 Deferred tax asset 2,008 2,024 Fair value of interest rate swaps 215 902 Above-market intangible assets, net 162 168 Right of use leased asset 141 — Other 267 335 $ 34,822 $ 34,546
Schedule of VIEs	The VIEs that we have identified at March 31, 2019 are summarized in the table below. Classification Carrying Amount (in millions) Maximum Exposure to Loss (in millions) Notes receivable $ 0.9 $ 0.9 Note receivable $ 23.0 $ 23.0 Highlands Transition Update As previously announced, the Company experienced payment issues with the old operator of Highlands Hospital ("Highlands"). Effective February 11, 2019, the Company signed a transition agreement (the "Transition Agreement"), to transition the property to a new operator and signed a lease with a new operator. The old operator and new operator have signed an asset purchase agreement pursuant to which the new operator will take over the facility. In addition, the old operator and new operator have signed a management agreement and the new operator is currently managing Highlands pursuant to the management agreement. The new operator continues to perform due diligence and is in the process of preparing for transfer of licenses and related items customary for these types of transactions. We cannot provide assurance as to the timing, or whether, this transaction will actually close. The new lease will be effective upon the transfer of the licenses to the new operator, which is anticipated to happen in the second half of 2019. The new lease provides for rental payments approximately equal to the amounts due under the previous agreements with the old operator. The Company is receiving monthly payments under the Transition Agreement which approximate the amounts due from the old operator under the previous agreements. These payments are to continue as long as the Transition Agreement is in place. The Transition Agreement will terminate when the licenses are transferred to the new operator, at which time the new lease will become effective. Since the Transition Agreement became effective in February, the Company only received payments during the first quarter for February and March and thus did not recognize revenue for the month of January representing approximately $0.3 million . In addition, the Company incurred professional fees (legal and accounting) totaling over $0.1 million related to the workout and transition. The Transition Agreement includes provisions for the Company to receive payment for the amounts due from the old operator that remain unpaid. The Company anticipates collecting all amounts due.

Fair Value of Financial Instr_2

Fair Value of Financial Instruments (Tables)	3 Months Ended
	Mar. 31, 2019
Fair Value Disclosures [Abstract]
Fair Value, by Balance Sheet Grouping	The table below details the fair values and carrying values for our notes receivable, interest rate swaps, and mortgage note payable at March 31, 2019 and December 31, 2018 , using level 2 inputs. March 31, 2019 December 31, 2018 (Dollars in thousands) Carrying Value Fair Value Carrying Value Fair Value Notes receivable $ 24,119 $ 23,948 $ 24,110 $ 23,936 Interest rate swap asset $ 215 $ 215 $ 902 $ 902 Interest rate swap liability $ 857 $ 857 $ 269 $ 269 Mortgage note payable $ 5,365 $ 5,277 $ 5,391 $ 5,307

Summary of Significant Accoun_3

Summary of Significant Accounting Policies - Business Overview/Segment Reporting (Details) $ in Thousands, ft² in Millions	3 Months Ended
	Mar. 31, 2018USD ($)	Mar. 31, 2019USD ($)ft²statereal_estate_property	Jan. 01, 2019USD ($)lease	Dec. 31, 2018USD ($)
Disaggregation of Revenue [Line Items]
Value of real estate property investments and mortgages		$ 478,400
Number of real estate properties | real_estate_property		105
Number of states in which real estate investments are in | state		29
Area of real estate property (in square feet) | ft²		2.3
Operating lease ROU assets		$ 141		$ 0
Tenant reimbursements
Disaggregation of Revenue [Line Items]
Revenue	$ 1,400
ASU 2016-02
Disaggregation of Revenue [Line Items]
Operating lease ROU assets			$ 100
Operating lease liabilities			$ 100
Number of ground leases | lease			1

Real Estate Investments - Addit

Real Estate Investments - Additional Information (Details) $ in Millions	Mar. 31, 2019USD ($)real_estate_property
Real Estate [Abstract]
Value of real estate property investments and mortgages | $	$ 478.4
Number of real estate properties | real_estate_property	105

Real Estate Investments - Sched

Real Estate Investments - Schedule of Real Estate Property Investments (Details) $ in Thousands	Mar. 31, 2019USD ($)real_estate_property	Dec. 31, 2018USD ($)
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	105
Land and Land Improvements	$ 52,520	$ 50,270
Buildings, Improvements, and Lease Intangibles	425,763	394,527
Personal Property	135	133
Total real estate properties	478,418	444,930
Accumulated Depreciation	$ 60,544	$ 55,298
Medical office [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	35
Land and Land Improvements	$ 21,548
Buildings, Improvements, and Lease Intangibles	142,965
Total real estate properties	164,513
Accumulated Depreciation	$ 28,449
Medical office [Member] | Florida [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	5
Land and Land Improvements	$ 4,608
Buildings, Improvements, and Lease Intangibles	29,285
Total real estate properties	33,893
Accumulated Depreciation	$ 4,515
Medical office [Member] | Illinois [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	2
Land and Land Improvements	$ 1,136
Buildings, Improvements, and Lease Intangibles	11,831
Total real estate properties	12,967
Accumulated Depreciation	$ 2,664
Medical office [Member] | Iowa [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	1
Land and Land Improvements	$ 2,241
Buildings, Improvements, and Lease Intangibles	9,014
Total real estate properties	11,255
Accumulated Depreciation	$ 2,468
Medical office [Member] | Kansas [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	3
Land and Land Improvements	$ 2,455
Buildings, Improvements, and Lease Intangibles	14,933
Total real estate properties	17,388
Accumulated Depreciation	$ 4,189
Medical office [Member] | Ohio [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	6
Land and Land Improvements	$ 3,638
Buildings, Improvements, and Lease Intangibles	26,483
Total real estate properties	30,121
Accumulated Depreciation	$ 5,508
Medical office [Member] | Other States [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	15
Land and Land Improvements	$ 4,355
Buildings, Improvements, and Lease Intangibles	35,828
Total real estate properties	40,183
Accumulated Depreciation	$ 4,649
Medical office [Member] | Texas [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	3
Land and Land Improvements	$ 3,115
Buildings, Improvements, and Lease Intangibles	15,591
Total real estate properties	18,706
Accumulated Depreciation	$ 4,456
Physician clinics [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	21
Land and Land Improvements	$ 6,654
Buildings, Improvements, and Lease Intangibles	47,406
Total real estate properties	54,060
Accumulated Depreciation	$ 6,396
Physician clinics [Member] | Florida [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	4
Land and Land Improvements	$ 253
Buildings, Improvements, and Lease Intangibles	9,484
Total real estate properties	9,737
Accumulated Depreciation	$ 912
Physician clinics [Member] | Illinois [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	6
Land and Land Improvements	$ 2,888
Buildings, Improvements, and Lease Intangibles	9,539
Total real estate properties	12,427
Accumulated Depreciation	$ 540
Physician clinics [Member] | Kansas [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	2
Land and Land Improvements	$ 610
Buildings, Improvements, and Lease Intangibles	6,921
Total real estate properties	7,531
Accumulated Depreciation	$ 1,485
Physician clinics [Member] | Other States [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	9
Land and Land Improvements	$ 2,903
Buildings, Improvements, and Lease Intangibles	21,462
Total real estate properties	24,365
Accumulated Depreciation	$ 3,459
Surgical Centers and Hospitals [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	15
Land and Land Improvements	$ 7,646
Buildings, Improvements, and Lease Intangibles	68,168
Total real estate properties	75,814
Accumulated Depreciation	$ 11,576
Surgical Centers and Hospitals [Member] | Arizona [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	2
Land and Land Improvements	$ 576
Buildings, Improvements, and Lease Intangibles	5,389
Total real estate properties	5,965
Accumulated Depreciation	$ 1,603
Surgical Centers and Hospitals [Member] | Florida [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	1
Land and Land Improvements	$ 271
Buildings, Improvements, and Lease Intangibles	7,069
Total real estate properties	7,340
Accumulated Depreciation	$ 810
Surgical Centers and Hospitals [Member] | Illinois [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	2
Land and Land Improvements	$ 2,349
Buildings, Improvements, and Lease Intangibles	8,222
Total real estate properties	10,571
Accumulated Depreciation	$ 1,411
Surgical Centers and Hospitals [Member] | Louisiana [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	1
Land and Land Improvements	$ 1,683
Buildings, Improvements, and Lease Intangibles	21,353
Total real estate properties	23,036
Accumulated Depreciation	$ 1,244
Surgical Centers and Hospitals [Member] | Michigan [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	2
Land and Land Improvements	$ 637
Buildings, Improvements, and Lease Intangibles	8,278
Total real estate properties	8,915
Accumulated Depreciation	$ 2,434
Surgical Centers and Hospitals [Member] | Other States [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	7
Land and Land Improvements	$ 2,130
Buildings, Improvements, and Lease Intangibles	17,857
Total real estate properties	19,987
Accumulated Depreciation	$ 4,074
Specialty Centers [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	25
Land and Land Improvements	$ 8,659
Buildings, Improvements, and Lease Intangibles	63,077
Total real estate properties	71,736
Accumulated Depreciation	$ 9,448
Specialty Centers [Member] | Illinois [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	3
Land and Land Improvements	$ 3,489
Buildings, Improvements, and Lease Intangibles	24,733
Total real estate properties	28,222
Accumulated Depreciation	$ 2,117
Specialty Centers [Member] | Other States [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	22
Land and Land Improvements	$ 5,170
Buildings, Improvements, and Lease Intangibles	38,344
Total real estate properties	43,514
Accumulated Depreciation	$ 7,331
Behavioral facilities [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	7
Land and Land Improvements	$ 5,975
Buildings, Improvements, and Lease Intangibles	60,580
Total real estate properties	66,555
Accumulated Depreciation	$ 3,062
Behavioral facilities [Member] | Illinois [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	1
Land and Land Improvements	$ 1,300
Buildings, Improvements, and Lease Intangibles	18,803
Total real estate properties	20,103
Accumulated Depreciation	$ 1,332
Behavioral facilities [Member] | Indiana [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	2
Land and Land Improvements	$ 1,126
Buildings, Improvements, and Lease Intangibles	6,040
Total real estate properties	7,166
Accumulated Depreciation	$ 351
Behavioral facilities [Member] | Other States [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	3
Land and Land Improvements	$ 1,411
Buildings, Improvements, and Lease Intangibles	12,840
Total real estate properties	14,251
Accumulated Depreciation	$ 499
Behavioral facilities [Member] | West Virginia [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	1
Land and Land Improvements	$ 2,138
Buildings, Improvements, and Lease Intangibles	22,897
Total real estate properties	25,035
Accumulated Depreciation	$ 880
Inpatient Rehabilitation Facilities [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	1
Land and Land Improvements	$ 1,515
Buildings, Improvements, and Lease Intangibles	27,001
Total real estate properties	28,516
Accumulated Depreciation	$ 82
Inpatient Rehabilitation Facilities [Member] | Texas [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	1
Land and Land Improvements	$ 1,515
Buildings, Improvements, and Lease Intangibles	27,001
Total real estate properties	28,516
Accumulated Depreciation	$ 82
Long-Term Acute Care Hospitals [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	1
Land and Land Improvements	$ 523
Buildings, Improvements, and Lease Intangibles	14,405
Total real estate properties	14,928
Accumulated Depreciation	$ 1,222
Long-Term Acute Care Hospitals [Member] | Indiana [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	1
Land and Land Improvements	$ 523
Buildings, Improvements, and Lease Intangibles	14,405
Total real estate properties	14,928
Accumulated Depreciation	$ 1,222
Corporate property [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	0
Land and Land Improvements	$ 0
Buildings, Improvements, and Lease Intangibles	2,161
Personal Property	135
Total real estate properties	2,296
Accumulated Depreciation	$ 309

Real Estate Leases (Details)

Real Estate Leases (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018
Real Estate [Line Items]
2019 (nine months ending December 31)	$ 32,823
2020	41,304
2021	38,200
2022	34,688
2023	30,177
2024 and thereafter	156,754
Total	333,946
Straight Line rent	336	$ 415
Other Liabilities [Member]
Real Estate [Line Items]
Deferred revenue	$ 1,500		$ 1,600

Real Estate Acquisitions (Detai

Real Estate Acquisitions (Details) ft² in Thousands, $ in Millions	3 Months Ended
	Mar. 31, 2019USD ($)ft²real_estate_property
Business Acquisition [Line Items]
Area of real estate property (in square feet) | ft²	2,300
Acquisition Of Two Properties During 1st Quarter 2019 [Member]
Business Acquisition [Line Items]
Number of properties acquired | real_estate_property	2
Area of real estate property (in square feet) | ft²	83
Consideration transferred	$ 32.7
Percentage of properties that were leased at acquisition	100.00%
Revenue from properties acquired	$ 0.4
Net income from properties acquired	0.2
Transaction costs	$ 0.1

Mortgage and Other Notes Rece_2

Mortgage and Other Notes Receivable (Details) $ in Thousands	Apr. 25, 2018USD ($)hospital	Dec. 28, 2017USD ($)real_estate_property	Mar. 31, 2019USD ($)	Mar. 31, 2018USD ($)	Dec. 31, 2018USD ($)	Dec. 31, 2017USD ($)mortgage_note_receivable
Accounts, Notes, Loans and Financing Receivable [Line Items]
Mortgage note receivable, net						$ 10,600
Notes receivable			$ 24,119		$ 24,110
Proceeds from the repayment of notes receivable			31	$ 17
Repayments of mortgage note payable	$ 6,700		27	0
Real estate property			$ 417,874		389,632
Mortgage Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of mortgage note receivables | mortgage_note_receivable						1
Promissory Notes, Secured by Accounts Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Mortgage loans on real estate, face amount of mortgages		$ 11,450
Notes receivable		8,750
Receivable with imputed interest, discount		2,700
Promissory Notes, Secured By Facilities Owned By Borrower [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Notes receivable	23,000			$ 2,200
Notes Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Notes receivable					$ 900
Proceeds from the repayment of notes receivable		$ 10,950
Proceeds from the repayment of notes receivable, interest	260
Proceeds from the repayment of notes receivable, fees and expenses	$ 250
Other Assets [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest receivable						$ 600
Long-Term Acute Care Facility [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of properties used to secure notes by borrower | hospital	7
Inpatient Rehabilitation Hospital [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of properties used to secure notes by borrower | hospital	1
Specialty Hospital [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of properties used to secure notes by borrower | real_estate_property		2
Property Previously Financed By Mortgage Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Real estate property	$ 4,500

Debt, net - Schedule of Debt (D

Debt, net - Schedule of Debt (Details) - USD ($) $ in Thousands	Mar. 31, 2019	Dec. 31, 2018
Debt Instrument [Line Items]
Debt, net	$ 179,117	$ 147,766
Term Loan [Member] | Third Amended And Restated Credit Facility [Member]
Debt Instrument [Line Items]
Debt, net	175,000
Mortgage Note Payable [Member]
Debt Instrument [Line Items]
Debt, net	5,263	5,285
Revolving Credit Facility [Member] | Line of Credit [Member] | Third Amended And Restated Credit Facility [Member]
Debt Instrument [Line Items]
Debt, net	0	43,000
A-1 Term Loan [Member] | Term Loan [Member] | Third Amended And Restated Credit Facility [Member]
Debt Instrument [Line Items]
Debt, net	49,778	49,759
A-2 Term Loan [Member] | Term Loan [Member] | Third Amended And Restated Credit Facility [Member]
Debt Instrument [Line Items]
Debt, net	49,735	49,722
A-3 Term Loan [Member] | Term Loan [Member] | Third Amended And Restated Credit Facility [Member]
Debt Instrument [Line Items]
Debt, net	$ 74,341	$ 0

Debt, net - Narrative (Details)

Debt, net - Narrative (Details)	Mar. 29, 2019USD ($)option	Mar. 31, 2019USD ($)	Mar. 31, 2018USD ($)	Dec. 31, 2018USD ($)
Line of Credit Facility [Line Items]
Debt issuance costs		$ 1,323,000	$ 218,000
Amount outstanding		179,117,000		$ 147,766,000
Third Amended And Restated Credit Facility [Member]
Line of Credit Facility [Line Items]
Debt issuance costs	$ 1,300,000
Third Amended And Restated Credit Facility [Member] | Term Loan [Member]
Line of Credit Facility [Line Items]
Face amount	$ 175,000,000
Unused borrowing commitment fee percentage	0.35%
Amount outstanding		$ 175,000,000
Weighted average interest rate percentage		4.569%
Third Amended And Restated Credit Facility [Member] | London Interbank Offered Rate (LIBOR) [Member] | Minimum [Member] | Term Loan [Member]
Line of Credit Facility [Line Items]
Variable rate percentage	1.25%
Third Amended And Restated Credit Facility [Member] | London Interbank Offered Rate (LIBOR) [Member] | Maximum [Member] | Term Loan [Member]
Line of Credit Facility [Line Items]
Variable rate percentage	2.30%
Third Amended And Restated Credit Facility [Member] | Base Rate [Member] | Minimum [Member] | Term Loan [Member]
Line of Credit Facility [Line Items]
Variable rate percentage	0.25%
Third Amended And Restated Credit Facility [Member] | Base Rate [Member] | Maximum [Member] | Term Loan [Member]
Line of Credit Facility [Line Items]
Variable rate percentage	1.30%
Third Amended And Restated Credit Facility [Member] | Revolving Credit Facility [Member]
Line of Credit Facility [Line Items]
Debt issuance costs	$ 700,000
Third Amended And Restated Credit Facility [Member] | Revolving Credit Facility [Member] | Line of Credit [Member]
Line of Credit Facility [Line Items]
Maximum borrowing capacity	$ 150,000,000
Number of options to extend | option	1
Length of extension	12 months
Remaining borrowing capacity	$ 150,000,000
Amount outstanding		$ 0		43,000,000
Third Amended And Restated Credit Facility [Member] | Revolving Credit Facility [Member] | London Interbank Offered Rate (LIBOR) [Member] | Minimum [Member] | Line of Credit [Member]
Line of Credit Facility [Line Items]
Variable rate percentage	1.25%
Third Amended And Restated Credit Facility [Member] | Revolving Credit Facility [Member] | London Interbank Offered Rate (LIBOR) [Member] | Maximum [Member] | Line of Credit [Member]
Line of Credit Facility [Line Items]
Variable rate percentage	1.90%
Third Amended And Restated Credit Facility [Member] | Revolving Credit Facility [Member] | Base Rate [Member] | Minimum [Member] | Line of Credit [Member]
Line of Credit Facility [Line Items]
Variable rate percentage	0.25%
Third Amended And Restated Credit Facility [Member] | Revolving Credit Facility [Member] | Base Rate [Member] | Maximum [Member] | Line of Credit [Member]
Line of Credit Facility [Line Items]
Variable rate percentage	0.90%
Third Amended And Restated Credit Facility [Member] | Credit Facility, Accordion Feature [Member]
Line of Credit Facility [Line Items]
Maximum borrowing capacity	$ 525,000,000
Third Amended And Restated Credit Facility [Member] | A-1 Term Loan [Member] | Term Loan [Member]
Line of Credit Facility [Line Items]
Face amount	$ 50,000,000
Debt term	5 years
Amount outstanding		49,778,000		49,759,000
Third Amended And Restated Credit Facility [Member] | A-2 Term Loan [Member] | Term Loan [Member]
Line of Credit Facility [Line Items]
Face amount	$ 50,000,000
Debt term	7 years
Amount outstanding		49,735,000		49,722,000
Third Amended And Restated Credit Facility [Member] | A-3 Term Loan [Member]
Line of Credit Facility [Line Items]
Debt issuance costs	$ 600,000
Third Amended And Restated Credit Facility [Member] | A-3 Term Loan [Member] | Term Loan [Member]
Line of Credit Facility [Line Items]
Face amount	$ 75,000,000
Debt term	7 years
Amount outstanding		$ 74,341,000		$ 0
Third Amended And Restated Credit Facility [Member] | Revolving Credit Facility, Unused Borrowing Capacity Rate 1 [Member] | Line of Credit [Member]
Line of Credit Facility [Line Items]
Unused borrowing commitment fee percentage	0.25%
Percentage of borrowing capacity outstanding	33.30%
Third Amended And Restated Credit Facility [Member] | Revolving Credit Facility, Unused Borrowing Capacity Rate 2 [Member] | Line of Credit [Member]
Line of Credit Facility [Line Items]
Unused borrowing commitment fee percentage	0.35%
Percentage of borrowing capacity outstanding	33.30%

Derivative Financial Instrume_3

Derivative Financial Instruments - Narrative (Details) $ in Millions	3 Months Ended
	Mar. 31, 2019USD ($)derivative_instrument
Derivative [Line Items]
Cash flow hedges reclassified to interest expense	$ 0.2
Cash Flow Hedging [Member] | Interest Rate Contract [Member]
Derivative [Line Items]
Number outstanding interest rate derivatives | derivative_instrument	7
Notional amount	$ 175
Termination value	0.7
Designated as Hedging Instrument [Member] | Cash Flow Hedging [Member] | Interest Rate Swap [Member]
Derivative [Line Items]
Interest rate swap liability	$ 0.7

Derivative Financial Instrume_4

Derivative Financial Instruments - Fair Value Balance Sheet (Details) - USD ($) $ in Thousands	Mar. 31, 2019	Dec. 31, 2018
Derivatives, Fair Value [Line Items]
Derivative asset	$ 215	$ 902
Cash Flow Hedging [Member] | Interest Rate Swap [Member] | Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative liability	700
Cash Flow Hedging [Member] | Interest Rate Swap [Member] | Designated as Hedging Instrument [Member] | Other Assets [Member]
Derivatives, Fair Value [Line Items]
Derivative asset	215	902
Cash Flow Hedging [Member] | Interest Rate Swap [Member] | Designated as Hedging Instrument [Member] | Other Liabilities [Member]
Derivatives, Fair Value [Line Items]
Derivative liability	$ 857	$ 98

Derivative Financial Instrume_5

Derivative Financial Instruments - Cash Flow Hedging (Details) - Interest Rate Contract [Member] - Cash Flow Hedging [Member] - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Derivative Instruments, Gain (Loss) [Line Items]
Amount of unrealized (loss) gain recognized in OCI on derivative	$ (1,213)	$ 906
Interest expense
Derivative Instruments, Gain (Loss) [Line Items]
Amount of (gain) loss reclassified from accumulated OCI into interest expense	(62)	68
Total Interest Expense presented in the Condensed Consolidated Statements of Income in which the effects of the cash flow hedges are recorded	$ 2,054	$ 1,268

Stockholders' Equity - Reconcil

Stockholders' Equity - Reconciliation of Common Stock (Details) - shares	3 Months Ended	12 Months Ended
	Mar. 31, 2019	Dec. 31, 2018
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance, beginning of period (in shares)	18,634,502	18,085,798
Issuance of common stock (in shares)	143,600	334,700
Restricted stock-based awards (in shares)	84,690	214,004
Balance, end of period (in shares)	18,862,792	18,634,502

Stockholders' Equity - Equity O

Stockholders' Equity - Equity Offering (Details) - USD ($)	Aug. 07, 2018	Mar. 31, 2019	Dec. 31, 2018
Subsidiary, Sale of Stock [Line Items]
Common Stock, par value (in dollars per share)		$ 0.01	$ 0.01
At The Market Offering Program [Member] | Common Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Common Stock, par value (in dollars per share)	$ 0.01
Value of shares authorized	$ 100,000,000
Shares issued in transaction (shares)		143,600
Proceeds from sale of stock		$ 4,700,000
Sales price (in dollars per share)		$ 33.57
Remaining availability under ATM program		$ 84,800,000

Net Income Per Common Share (De

Net Income Per Common Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Earnings Per Share [Abstract]
Net income	$ 1,450	$ 1,872
Participating securities' share in earnings	(324)	(241)
Net income, less participating securities' share in earnings	$ 1,126	$ 1,631
Weighted average Common Shares outstanding
Weighted average Common Shares outstanding (in shares)	18,735,673	18,164,132
Unvested restricted shares (in shares)	(781,003)	(590,449)
Weighted average Common Shares outstanding–Basic (in shares)	17,954,670	17,573,683
Dilutive effect of restricted stock (in shares)	0	0
Weighted average Common Shares outstanding –Diluted (in shares)	17,954,670	17,573,683
Basic Net Income per Common Share (in dollars per share)	$ 0.06	$ 0.09
Diluted Net Income per Common Share (in dollars per share)	$ 0.06	$ 0.09

Incentive Plan - Narrative (Det

Incentive Plan - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
2014 Incentive Plan [Member] | Restricted Common Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	$ 0.9	$ 0.6

Incentive Plan - Restricted Sto

Incentive Plan - Restricted Stock Activity (Details) - 2014 Incentive Plan [Member] - shares	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Restricted Common Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Stock-based awards, beginning of period (in shares)	709,487	512,115
Granted (in shares)	84,690	94,001
Vested shares (in shares)	0	0
Stock-based awards, end of period (in shares)	794,177	606,116
Restricted Common Stock, Stock in Lieu of Compensation [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Granted (in shares)	42,525	47,027
Restricted Common Stock, Stock Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Granted (in shares)	42,165	46,974

Other Assets - Other Assets (De

Other Assets - Other Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2019	Dec. 31, 2018
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Operating Lease, Right-of-Use Asset	$ 141	$ 0
Notes receivable	24,119	24,110
Accounts and interest receivables	2,092	2,158
Straight-line rent receivables	3,593	3,254
Prepaid assets	515	487
Deferred financing costs, net	848	318
Leasing commissions, net	862	790
Deferred tax asset	2,008	2,024
Fair value of interest rate swaps	215	902
Above-market intangible assets, net	162	168
Other	267	335
Other assets, net	$ 34,822	$ 34,546

Other Assets - Narrative (Detai

Other Assets - Narrative (Details) $ in Thousands	Apr. 25, 2018USD ($)hospital	Mar. 31, 2019USD ($)	Mar. 31, 2019USD ($)	Dec. 31, 2018USD ($)	Mar. 31, 2018USD ($)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Notes receivable		$ 24,119	$ 24,119	$ 24,110
Professional fees			$ 100
Notes Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Notes receivable				$ 900
Note receivable interest rate				9.00%
Promissory Notes, Secured By Facilities Owned By Borrower [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Notes receivable	$ 23,000				$ 2,200
Note receivable interest rate	9.00%
Long-Term Acute Care Facility [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of properties used to secure notes by borrower | hospital	7
Inpatient Rehabilitation Hospital [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of properties used to secure notes by borrower | hospital	1
Hospitals [Member] | Notes Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Proceeds from payments		$ 300

Other Assets - VIEs (Details)

Other Assets - VIEs (Details) - Notes Receivable [Member] $ in Millions	Mar. 31, 2019USD ($)
Variable Interest Entity One [Member]
Variable Interest Entity [Line Items]
Carrying Amount	$ 0.9
Maximum Exposure to Loss	0.9
Variable Interest Entity Two [Member]
Variable Interest Entity [Line Items]
Carrying Amount	23
Maximum Exposure to Loss	$ 23

Fair Value of Financial Instr_3

Fair Value of Financial Instruments (Details) - USD ($) $ in Thousands	Mar. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Mortgage note receivable			$ 10,600
Notes receivable	$ 24,119	$ 24,110
Interest rate swap asset	215	902
Carrying Value [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Notes receivable	24,119	24,110
Mortgage note payable	5,365	5,391
Carrying Value [Member] | Interest Rate Swap [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Interest rate swap asset	215	902
Interest rate swap liability	857	269
Fair Value [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Notes receivable	23,948	23,936
Mortgage note payable	5,277	5,307
Fair Value [Member] | Interest Rate Swap [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Interest rate swap asset	215	902
Interest rate swap liability	$ 857	$ 269

Subsequent Events (Details)

Subsequent Events (Details) $ / shares in Units, ft² in Thousands, $ in Millions	May 01, 2019$ / shares	Apr. 30, 2019USD ($)ft²real_estate_property	Mar. 31, 2019ft²
Subsequent Event [Line Items]
Area of real estate property (in square feet) | ft²			2,300
Subsequent Event [Member]
Subsequent Event [Line Items]
Dividend declared (in dollars per share) | $ / shares	$ 0.41
Number of properties acquired | real_estate_property		1
Area of real estate property (in square feet) | ft²		81
Consideration transferred | $		$ 27
Percentage of properties that were leased at acquisition		100.00%
Revolving Credit Facility [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Draw on credit facility | $		$ 23